Peripheral Vascular Disease (PVD) is narrowing of arteries outside the brain and heart. Peripheral vascular disease also is caused due to accumulation of plaque within the inside lining of arteries. There are certain risk factors for the growth PVD such as hypertension, obesity, diabetes and smoking. Insufficient blood flow and narrowing of arteries are the most common peripheral diseases caused due to plaque buildup. Higher incidence rate of lifestyle diseases such as diabetes and obesity, geriatric population and high unmet need are the major factors driving the growth of the global peripheral vascular devices market.
The global peripheral vascular devices market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global peripheral vascular devices market segmentation is based on product types (peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, inferior vena cava filters).
The global peripheral vascular devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global peripheral vascular devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global peripheral vascular devices market and included in this report are Abbott Laboratories, Boston Scientific Corporation, C. R. Bard Inc., Cordis Corporation, Medtronic and others.